Cargando…
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
Lyme disease is the most common zoonotic bacterial disease in North America. It is estimated that >300,000 cases per annum are reported in USA alone. A total of 10%–20% of patients who have been treated with antibiotic therapy report the recrudescence of symptoms, such as muscle and joint pain, p...
Autores principales: | Pothineni, Venkata Raveendra, Wagh, Dhananjay, Babar, Mustafeez Mujtaba, Inayathullah, Mohammed, Solow-Cordero, David, Kim, Kwang-Min, Samineni, Aneesh V, Parekh, Mansi B, Tayebi, Lobat, Rajadas, Jayakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827596/ https://www.ncbi.nlm.nih.gov/pubmed/27103785 http://dx.doi.org/10.2147/DDDT.S101486 |
Ejemplares similares
-
In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2018) -
Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition
por: Wagh, Dhananjay, et al.
Publicado: (2015) -
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020) -
Effect of osmolytes on the conformation and aggregation of some amyloid peptides: CD spectroscopic data
por: Inayathullah, Mohammed, et al.
Publicado: (2016)